Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
File(s)LF trajectories Main text-2nd revision-clean.docx (151.21 KB) Supplements LF trajectory_14-Feb.docx (60.87 KB)
Accepted version
Supporting information
Author(s)
Type
Journal Article
Abstract
Background
Lifetime lung function is related to quality of life and longevity. Over the lifespan, individuals follow different lung function trajectories. It is important to identify these trajectories, their determinants and outcomes but no study has done this beyond the fourth decade.
Methods
We modelled trajectories of forced expiratory volume in 1 second (FEV1) measured at 7, 13, 18, 45, 50 and 53 years (n=2438). The trajectories identified were then related to childhood factors and Chronic Obstructive Pulmonary Disease (COPD) risk.
Findings
Six trajectories were identified: “early below average, accelerated decline” (4%, n=97), “persistently low” (5·6%, n=136), “below average” (31·6%, n=772), “persistently high” (12·1%, n=293), “early low, accelerated growth, normal decline” (8%, n=196), and “average” (38·7%, n=944). The first three trajectories had increased risk of COPD at age 53 compared with the average group: OR 35(95%CI 19·5-64); 9·5(4·5-20·6); and 3·7(1·9-6·9) respectively. Early-life predictors of the three trajectories included childhood asthma, bronchitis, pneumonia, hayfever, eczema, parental asthma, and maternal smoking. Personal smoking and active adult asthma increased the impact of maternal smoking and childhood asthma respectively on the “early below average, accelerated decline” trajectory.
Interpretation
We identified six potential FEV1 trajectories, two of which were novel. Three trajectories contributed 75% of COPD burden and were associated with modifiable early-life exposures whose impact was aggravated by adult factors. We postulate that reducing maternal smoking; encouraging immunization; and avoiding personal smoking, especially in those with smoking parents and/or low childhood lung function, may minimize COPD risk. Clinicians and asthmatic patients should be made aware of the potential long-term implications of non-optimal asthma control for lung function trajectory throughout life, and this should be investigated in future intervention trials.
Lifetime lung function is related to quality of life and longevity. Over the lifespan, individuals follow different lung function trajectories. It is important to identify these trajectories, their determinants and outcomes but no study has done this beyond the fourth decade.
Methods
We modelled trajectories of forced expiratory volume in 1 second (FEV1) measured at 7, 13, 18, 45, 50 and 53 years (n=2438). The trajectories identified were then related to childhood factors and Chronic Obstructive Pulmonary Disease (COPD) risk.
Findings
Six trajectories were identified: “early below average, accelerated decline” (4%, n=97), “persistently low” (5·6%, n=136), “below average” (31·6%, n=772), “persistently high” (12·1%, n=293), “early low, accelerated growth, normal decline” (8%, n=196), and “average” (38·7%, n=944). The first three trajectories had increased risk of COPD at age 53 compared with the average group: OR 35(95%CI 19·5-64); 9·5(4·5-20·6); and 3·7(1·9-6·9) respectively. Early-life predictors of the three trajectories included childhood asthma, bronchitis, pneumonia, hayfever, eczema, parental asthma, and maternal smoking. Personal smoking and active adult asthma increased the impact of maternal smoking and childhood asthma respectively on the “early below average, accelerated decline” trajectory.
Interpretation
We identified six potential FEV1 trajectories, two of which were novel. Three trajectories contributed 75% of COPD burden and were associated with modifiable early-life exposures whose impact was aggravated by adult factors. We postulate that reducing maternal smoking; encouraging immunization; and avoiding personal smoking, especially in those with smoking parents and/or low childhood lung function, may minimize COPD risk. Clinicians and asthmatic patients should be made aware of the potential long-term implications of non-optimal asthma control for lung function trajectory throughout life, and this should be investigated in future intervention trials.
Date Issued
2018-07-01
Date Acceptance
2018-02-16
Citation
Lancet Respiratory Medicine, 2018, 6 (7), pp.535-544
ISSN
2213-2600
Publisher
Elsevier
Start Page
535
End Page
544
Journal / Book Title
Lancet Respiratory Medicine
Volume
6
Issue
7
Copyright Statement
© 2018 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor
Commission of the European Communities
Identifier
https://www.sciencedirect.com/science/article/pii/S2213260018301000?via%3Dihub
Grant Number
633212
Subjects
Science & Technology
Life Sciences & Biomedicine
Critical Care Medicine
Respiratory System
General & Internal Medicine
OBSTRUCTIVE PULMONARY-DISEASE
CIGARETTE-SMOKING
ASTHMA PHENOTYPES
REFERENCE VALUES
AGE
SPIROMETRY
HEALTH
GROWTH
PNEUMONIA
DECLINE
Adolescent
Adult
Age Distribution
Child
Child, Preschool
Cohort Studies
Female
Forced Expiratory Volume
Humans
Infant
Infant, Newborn
Longitudinal Studies
Lung
Male
Middle Aged
Prospective Studies
Pulmonary Disease, Chronic Obstructive
Respiratory Function Tests
Risk
Tasmania
Young Adult
Lung
Humans
Pulmonary Disease, Chronic Obstructive
Respiratory Function Tests
Forced Expiratory Volume
Risk
Cohort Studies
Longitudinal Studies
Prospective Studies
Age Distribution
Adolescent
Adult
Middle Aged
Child
Child, Preschool
Infant
Infant, Newborn
Tasmania
Female
Male
Young Adult
1103 Clinical Sciences
1117 Public Health and Health Services
1199 Other Medical and Health Sciences
Publication Status
Published
Date Publish Online
2018-04-05